83 related articles for article (PubMed ID: 11860866)
1. [Cost-effectiveness analysis of hepatitis B vaccination in People's Liberation Army].
Hu R; Cao W; Zhang X
Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Apr; 22(2):142-5. PubMed ID: 11860866
[TBL] [Abstract][Full Text] [Related]
2. [The use of decision making analysis for evaluating hepatitis B inoculation strategy].
Zhuang GH; Xu HW
Zhonghua Yu Fang Yi Xue Za Zhi; 1993 Mar; 27(2):69-73. PubMed ID: 8354107
[TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
Kim SY; Billah K; Lieu TA; Weinstein MC
Am J Prev Med; 2006 Jun; 30(6):498-506. PubMed ID: 16704944
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
[TBL] [Abstract][Full Text] [Related]
5. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
Hung HF; Chen TH
Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
[TBL] [Abstract][Full Text] [Related]
6. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
Vimolket T; Poovorawan Y
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):693-9. PubMed ID: 16124440
[TBL] [Abstract][Full Text] [Related]
7. [Study on the cost-effectiveness, benefit and utility analysis on the infant inoculation hepatitis B vaccine in Shanghai].
Wu GY; Gong YL; Yu SL; Shao RT; Qin HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):474-8. PubMed ID: 15231120
[TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates.
Jacobs RJ; Rosenthal P; Meyerhoff AS
Vaccine; 2004 Mar; 22(9-10):1241-8. PubMed ID: 15003653
[TBL] [Abstract][Full Text] [Related]
9. [Analysis on economic efficacy regarding previous strategies and current recommendations for vaccination against hepatitis B virus in China].
Zhang SX; Dang RB; Zhang WD; Liang XF; Cui FQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):1003-8. PubMed ID: 19173882
[TBL] [Abstract][Full Text] [Related]
10. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States.
Arguedas MR; Heudebert GR; Fallon MB; Stinnett AA
Am J Gastroenterol; 2002 Mar; 97(3):721-8. PubMed ID: 11922569
[TBL] [Abstract][Full Text] [Related]
11. [Epidemiology and cost-effectiveness analysis of hepatitis A vaccination in Liuzhou City].
Li X; Xu Z; Hofman A
Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Apr; 19(2):93-6. PubMed ID: 10322718
[TBL] [Abstract][Full Text] [Related]
12. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
Griffiths UK; Hutton G; Das Dores Pascoal E
Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A.
Jacobs RJ; Koff RS; Meyerhoff AS
Am J Gastroenterol; 2002 Feb; 97(2):427-34. PubMed ID: 11866283
[TBL] [Abstract][Full Text] [Related]
14. Primary high-dose intradermal hepatitis B vaccination in hemodialysis: cost-effectiveness evaluation at 2 years.
Mat O; Mestrez F; Beauwens R; Muniz-Martinez MC; Dhaene M
Hemodial Int; 2006 Jan; 10(1):49-55. PubMed ID: 16441827
[TBL] [Abstract][Full Text] [Related]
15. A low-dose intradermal hepatitis B vaccine programme in health-care workers and students is highly effective and cost saving: a retrospective follow-up survey in the clinical setting.
Sangfelt P; Uhnoo I; Reichard O; Weiland O
Scand J Gastroenterol; 2008; 43(4):465-72. PubMed ID: 18365912
[TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness and cost benefit of viral hepatitis B vaccination in the Slovak Republic.
Hudecková H; Straka S; Szilágyiová M; Avdicová M; Rusnáková S
Cent Eur J Public Health; 2002 Dec; 10(4):146-8. PubMed ID: 12528387
[TBL] [Abstract][Full Text] [Related]
17. Regional variation in the cost effectiveness of childhood hepatitis A immunization.
Jacobs RJ; Greenberg DP; Koff RS; Saab S; Meyerhoff AS
Pediatr Infect Dis J; 2003 Oct; 22(10):904-14. PubMed ID: 14551492
[TBL] [Abstract][Full Text] [Related]
18. Cost-benefit analysis of hepatitis a vaccination in Thailand.
Teppakdee A; Tangwitoon A; Khemasuwan D; Tangdhanakanond K; Suramaethakul N; Sriratanaban J; Poovorawan Y
Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):118-27. PubMed ID: 12118439
[TBL] [Abstract][Full Text] [Related]
19. Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis.
Plunkett BA; Grobman WA
Am J Obstet Gynecol; 2005 Apr; 192(4):1153-61. PubMed ID: 15846195
[TBL] [Abstract][Full Text] [Related]
20. Mathematical models of cervical cancer prevention in the Asia Pacific region.
Goldie SJ; Diaz M; Kim SY; Levin CE; Van Minh H; Kim JJ
Vaccine; 2008 Aug; 26 Suppl 12():M17-29. PubMed ID: 18945411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]